168 related articles for article (PubMed ID: 29705215)
1. Relationship between exposure to treosulfan and its monoepoxytransformer - An insight from population pharmacokinetic study in pediatric patients before hematopoietic stem cell transplantation.
Danielak D; Kasprzyk A; Wróbel T; Wachowiak J; Kałwak K; Główka F
Eur J Pharm Sci; 2018 Jul; 120():1-9. PubMed ID: 29705215
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT.
Główka F; Kasprzyk A; Romański M; Wróbel T; Wachowiak J; Szpecht D; Kałwak K; Wiela-Hojeńska A; Dziatkiewicz P; Teżyk A; Żaba C
Eur J Pharm Sci; 2015 Feb; 68():87-93. PubMed ID: 25527118
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.
Danielak D; Twardosz J; Kasprzyk A; Wachowiak J; Kałwak K; Główka F
Eur J Clin Pharmacol; 2018 Jan; 74(1):79-89. PubMed ID: 28975382
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Mohanan E; Panetta JC; Lakshmi KM; Edison ES; Korula A; Na F; Abraham A; Viswabandya A; George B; Mathews V; Srivastava A; Balasubramanian P
Clin Pharmacol Ther; 2018 Sep; 104(3):575-583. PubMed ID: 29247522
[TBL] [Abstract][Full Text] [Related]
5. Disposition of treosulfan and its active monoepoxide in a bone marrow, liver, lungs, brain, and muscle: Studies in a rat model with clinical relevance.
Romański M; Kasprzyk A; Walczak M; Ziółkowska A; Główka F
Eur J Pharm Sci; 2017 Nov; 109():616-623. PubMed ID: 28916482
[TBL] [Abstract][Full Text] [Related]
6. Formation Rate-Limited Pharmacokinetics of Biologically Active Epoxy Transformers of Prodrug Treosulfan.
Romański M; Kasprzyk A; Karbownik A; Szałek E; Główka FK
J Pharm Sci; 2016 May; 105(5):1790-1797. PubMed ID: 27044946
[TBL] [Abstract][Full Text] [Related]
7. Treosulfan Pharmacokinetics and its Variability in Pediatric and Adult Patients Undergoing Conditioning Prior to Hematopoietic Stem Cell Transplantation: Current State of the Art, In-Depth Analysis, and Perspectives.
Romański M; Wachowiak J; Główka FK
Clin Pharmacokinet; 2018 Oct; 57(10):1255-1265. PubMed ID: 29557088
[TBL] [Abstract][Full Text] [Related]
8. High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation.
Główka FK; Romański M; Wachowiak J
Expert Opin Investig Drugs; 2010 Oct; 19(10):1275-95. PubMed ID: 20836619
[TBL] [Abstract][Full Text] [Related]
9. Penetration of Treosulfan and its Active Monoepoxide Transformation Product into Central Nervous System of Juvenile and Young Adult Rats.
Romański M; Baumgart J; Böhm S; Główka FK
Drug Metab Dispos; 2015 Dec; 43(12):1946-54. PubMed ID: 26428246
[TBL] [Abstract][Full Text] [Related]
10. Activation of Prodrug Treosulfan at pH 7.4 and 37°C Accompanied by Hydrolysis of Its Active Epoxides: Kinetic Studies with Clinical Relevance.
Romański M; Urbaniak B; Kokot Z; Główka FK
J Pharm Sci; 2015 Dec; 104(12):4433-4442. PubMed ID: 26422826
[TBL] [Abstract][Full Text] [Related]
11. Determination of prodrug treosulfan and its biologically active monoepoxide in rat plasma, liver, lungs, kidneys, muscle, and brain by HPLC-ESI-MS/MS method.
Romański M; Kasprzyk A; Teżyk A; Widerowska A; Żaba C; Główka F
J Pharm Biomed Anal; 2017 Jun; 140():122-129. PubMed ID: 28346882
[TBL] [Abstract][Full Text] [Related]
12. Effect of Temperature on the Kinetics of the Activation of Treosulfan and Hydrolytic Decomposition of Its Active Epoxy Derivatives.
Romański M; Mikołajewski J; Główka FK
J Pharm Sci; 2017 Oct; 106(10):3156-3160. PubMed ID: 28600186
[TBL] [Abstract][Full Text] [Related]
13. Ocular disposition of treosulfan and its active epoxy-transformers following intravenous administration in rabbits.
Romański M; Kasprzyk A; Karbownik A; Główka FK
Drug Metab Pharmacokinet; 2016 Oct; 31(5):356-362. PubMed ID: 27662779
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation.
van der Stoep MYEC; Zwaveling J; Bertaina A; Locatelli F; Guchelaar HJ; Lankester AC; Moes DJAR
Br J Clin Pharmacol; 2019 Sep; 85(9):2033-2044. PubMed ID: 31144349
[TBL] [Abstract][Full Text] [Related]
15. Determination of partition coefficients n-octanol/water for treosulfan and its epoxy-transformers: an example of a negative correlation between lipophilicity of unionized compounds and their retention in reversed-phase chromatography.
Główka FK; Romański M; Siemiątkowska A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():92-7. PubMed ID: 23500352
[TBL] [Abstract][Full Text] [Related]
16. Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of protein-free pro-drug treosulfan and its biologically active monoepoxy-transformer in plasma and brain tissue.
Romański M; Teżyk A; Zaba C; Główka FK
Talanta; 2014 Sep; 127():123-32. PubMed ID: 24913866
[TBL] [Abstract][Full Text] [Related]
17. High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study.
van der Stoep MYEC; Bertaina A; Ten Brink MH; Bredius RG; Smiers FJ; Wanders DCM; Moes DJAR; Locatelli F; Guchelaar HJ; Zwaveling J; Lankester AC
Br J Haematol; 2017 Dec; 179(5):772-780. PubMed ID: 29048102
[TBL] [Abstract][Full Text] [Related]
18. Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing.
Bartelink IH; Boelens JJ; Bredius RG; Egberts AC; Wang C; Bierings MB; Shaw PJ; Nath CE; Hempel G; Zwaveling J; Danhof M; Knibbe CA
Clin Pharmacokinet; 2012 May; 51(5):331-45. PubMed ID: 22455797
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation for non-malignant diseases using treosulfan-based conditioning.
Dinur-Schejter Y; Krauss AC; Erlich O; Gorelik N; Yahel A; Porat I; Weintraub M; Stein J; Zaidman I; Stepensky P
Pediatr Blood Cancer; 2015 Feb; 62(2):299-304. PubMed ID: 25284797
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition in plasma and brain on the basis of a rat model.
Danielak D; Romański M; Kasprzyk A; Teżyk A; Główka F
Pharmacol Rep; 2020 Oct; 72(5):1297-1309. PubMed ID: 32474888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
